ArticleVaccine2009

Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial.

Paul Spearman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.